Autophagy inhibition decrease LAMP2 levels and survival of neuroendocrine differentiated LNCaP cells. by Cecilia Morell (729630)

PTPN12 decreases neurite-like outgrowth in TrkB-SH-SY5Y cells. by Malene Ambjørn (421718)

Fold decrease in virulence gene expression of <i>Salmonella in vivo</i> and <i>in vitro</i>^a. by Xiaojian Yang (295141)

“…Values represent down-regulation (fold-decrease) of gene expression.</p>#<p>Value for each gene represents a significant difference (<i>P</i><0.05) between the treatment and control samples in the <i>in vitro</i> experiment. …”

A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

“…The 5′- and 3′-untranslated regions are shown as grey boxes and the predicted mitochondrial targeting sequence is shown as a black box (predicted using MitoProtII, [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref040" target="_blank">40</a>]). …”

Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011) by Dong-Won Lee (2208223)

“…The prevalences of osteopenia and osteoporosis were 60.8% and 22.0%, respectively, in the sarcopenia group and 45.6% and 13.3% in the non-sarcopenia group (both p < 0.001). After adjusting for multiple variables, the presence of sarcopenia associated with increased the risk of osteopenia, osteoporosis, and a low BMD (OR = 3.227, 95% CI = 2.125–4.899, p < 0.001, OR = 6.952, 95% CI = 3.418–14.139, p < 0.001, and OR = 3.495, 95% CI = 2.315–5.278, p < 0.001, respectively). …”

Rank importance, where impairment at a point has a significant association with decreased vision-related quality of life. by Hiroshi Murata (387321)

Genes whose expression was decreased by 1 mM ouabain by more than 2-fold. by Larisa V. Smolyaninova (3600053)

Decreased biofilm formation in the Δ<i>tad123</i> mutant cells. by Tra-My Duong-Nu (7300970)

The effect of instilling the ophthalmic solution on the LF/HF ratio and typical cases of fluctuations in the LF/HF ratio over time in the DE and non-DE groups. by Minako Kaido (309626)

One-way migration distances calculated as mid–point to mid–point of their summer and winter geographic ranges. by Hector Galbraith (636637)

Non-cognate ternary complexes decrease the efficiency and robustness of duplex formation. by David N. Adamson (208890)

Table_1_v2_A long waiting time from diagnosis to treatment decreases the survival of non-small cell lung cancer patients with stage IA1: A retrospective study.docx by Bin Liu (5899)

“…After adjusting for other confounders, the waiting time was identified as an independent prognostic factor.</p>Conclusions<p>A long waiting time before treatment may decrease the survival of stage IA1 NSCLC patients. …”

Depletion of putative SDH subunits leads to decreased SDH activity and oxygen consumption. by Mariana F. Silva (10219520)

CD8+ T-cell interferon-gamma production and proliferation is decreased in <i>T</i>. <i>gondii</i>-infected HD mice. by David W. Donley (3111198)

“…Representative fluorescence histogram show IFN-γ production by CD8+ T-cells in spleen (<b>A</b>) and brain (<b>B</b>) in wild-type non-infected (gray filled), HD non-infected (gray-solid line), wild-type infected (black-solid line), and HD infected (black-dashed line) mice. …”

miR-146a and miR-155 levels decrease at the convalescent stage in patients with <i>V</i>. <i>cholerae</i> O1 infection. by Aziz Bitar (257322)

Mice exposed to neonatal hyperoxia have persistent RVH and decreased vessel density at 21d. by Marta Perez (526067)

Top 5 drug candidates for DDLB that showed the strongest binding affinity to the non-native structure and weaker affinity to the native structure. by Yang Jiang (46459)

Top 5 drugs for CAT-III that showed the strongest binding affinity to the non-native structure and no binding affinity to the native structure. by Yang Jiang (46459)

Sequence comparisons of <i>dim2</i> alleles in <i>Z</i>. by Mareike Möller (5548745)

Subjects:

TLR agonists decrease ZIKV replication. by Fiorella Rossi (134126)